3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
5
Urothelial Carcinoma of the Bladder
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Choroid Plexus Neoplasms
1
Childhood Solid Tumor
1
Central Nervous System Neoplasms
1
Interventions
Bevacizumab
21
Paclitaxel
18
Carboplatin
13
pembrolizumab
11
olaparib
10
liposomal doxorubicin
10
Gemcitabine
9
Cyclophosphamide
9
Specimen Handling
8
Topotecan
7
Magnetic Resonance Spectroscopy
7
fludarabine
6
Fulvestrant
6
Taxes
5
Immunoglobulin G
5
Disulfides
5
palbociclib
4
niraparib
4
mirvetuximab soravtansine
4
Oxaliplatin
4
Nivolumab
4
Biopsy
4
trastuzumab deruxtecan
3
ipatasertib
3
cediranib
3
capivasertib
3
atezolizumab
3
aldesleukin
3
Leucovorin
3
Fluorouracil
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Vinblastine
×
30 days
×
Clear all
No trials found.